G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration

British Journal of Cancer

Volumn 110, Issue 5, 2014, Pages 1211-1220

  Morris, K T ^a   Khan, H ^a   Ahmad, A ^a   Weston, L L ^a   Nofchissey, R A ^a   Pinchuk, I V ^b   Beswick, E J ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Colon cancer; G CSF; G CSFR; Gastric cancer; Stem cells

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOTRANSFERASE; RSK1 ENZYME; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL ISOLATION; CELL MIGRATION; COLON CANCER; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

CACO-2 CELLS; CARCINOMA; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MAP KINASE SIGNALING SYSTEM; MYOFIBROBLASTS; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; STOMACH NEOPLASMS;

EID: 84895808125     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.822     Document Type: Article

References (39)

1. Amariglio N, Jacob-Hirsch J, Shimoni A, Leiba M, Rechavi G, Nagler A (2007) Changes in gene expression pattern following granulocyte colonystimulating factor administration to normal stem cell sibling donors. Acta Haematol 117(2): 68-73.
2. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255): 539-545. (Pubitemid 32173595)
3. Carpentino JE, Hynes MJ, Appelman HD, Zheng T, Steindler DA, Scott EW, Huang EH (2009) Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. Cancer Res 69(20): 8208-8215.
4. Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58: 267-284. (Pubitemid 46706514)
5. Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang LP, Roby KF, Orsulic S, Connolly DC, Zhang Y, Montone K, Butzow R, Coukos G, Zhang L (2010) Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 5(4): e10277.
6. Fujii K, Ishimaru F, Kozuka T, Matsuo K, Nakase K, Kataoka I, Tabayashi T, Shinagawa K, Ikeda K, Harada M, Tanimoto M (2004) Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Br J Haematol 124(2): 190-194. (Pubitemid 38122191)
7. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN (1994) Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35(11): 1590-1592. (Pubitemid 24339258)
8. Gutschalk CM, Herold-Mende CC, Fusenig NE, Mueller MM (2006) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res 66(16): 8026-8036. (Pubitemid 44299167)
9. Held TK, Gundert-Remy U (2010) Pharmacodynamic effects of haematopoietic cytokines: the view of a clinical oncologist. Basic Clin Pharmacol Toxicol 106(3): 210-214.
10. Hirai K, Kumakiri M, Fujieda S, Sunaga H, Lao LM, Imamura Y, Ueda K, Fukuda M (2001) Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors. J Dermatol Sci 25(3): 179-188. (Pubitemid 32184505)
11. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69(8): 3382-3389.
12. Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19(8): 1893-1907.
13. Jiang W, Peng J, Zhang Y, Cho WC, Jin K (2012) The implications of cancer stem cells for cancer therapy. Int J Mol Sci 13(12): 16636-16657.
14. Kamezaki K, Shimoda K, Numata A, Haro T, Kakumitsu H, Yoshie M, Yamamoto M, Takeda K, Matsuda T, Akira S, Ogawa K, Harada M (2005) Roles of Stat3 and ERK in G-CSF signaling. Stem Cells 23(2): 252-263. (Pubitemid 40239520)
15. Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K (2012) Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinomainitiating cells is inhibited by TGF-beta. J Pathol 228(3): 391-404.
16. Liongue C, Wright C, Russell AP, Ward AC (2009) Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int J Biochem Cell Biol 41(12): 2372-2375.
17. Lobo NA, Shimono Y, Qian D, Clarke MF (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699.
18. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z (2012) Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines. Tumour Biol 33(4): 967-978.
19. Marino VJ, Roguin LP (2008) The granulocyte colony stimulating factor (G-CSF) activates Jak/STAT and MAPK pathways in a trophoblastic cell line. J Cell Biochem 103(5): 1512-1523. (Pubitemid 351490719)
20. McGuire TR, Kessinger A, Hock L, Sharp JG (2001) Elevated transforming growth factor beta levels in the plasma of cytokine-treated cancer patients and normal allogeneic stem cell donors. Cytotherapy 3(5): 361-364. (Pubitemid 34784629)
21. Morstyn G, Campbell L, Lieschke G, Layton JE, Maher D, O'Connor M, Green M, Sheridan W, Vincent M, Alton K (1989) Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol 7(10): 1554-1562. (Pubitemid 19245129)
22. Ninci EB, Brandstetter T, Meinhold-Heerlein I, Bettendorf H, Sellin D, Bauknecht T (2000) G-CSF receptor expression in ovarian cancer. Int J Gynecol Cancer 10(1): 19-26. (Pubitemid 30219474)
23. Ohata H, Ishiguro T, Aihara Y, Sato A, Sakai H, Sekine S, Taniguchi H, Akasu T, Fujita S, Nakagama H, Okamoto K (2012) Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells. Cancer Res 72(19): 5101-5110.
24. Pinchuk IV, Morris KT, Nofchissey RA, Earley RB, Wu JY, Ma TY, Beswick EJ (2013) Stromal cells induce Th17 during Helicobacter pylori infection and in the gastric tumor microenvironment. PLoS ONE 8(1): e53798.
25. Saada JI, Pinchuk IV, Barrera CA, Adegboyega PA, Suarez G, Mifflin RC, Di Mari JF, Reyes VE, Powell DW (2006) Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. J Immunol 177(9): 5968-5979. (Pubitemid 44628810)
26. Sampson M, Zhu QS, Corey SJ (2007) Src kinases in G-CSF receptor signaling. Front Biosci 12: 1463-1474. (Pubitemid 46846845)
27. Seelentag W, Mermod JJ, Vassalli P (1989) Interleukin 1 and tumor necrosis factor-alpha additively increase the levels of granulocyte-macrophage and granulocyte colony-stimulating factor (CSF) mRNA in human fibroblasts. Eur J Immunol 19(1): 209-212. (Pubitemid 19069312)
28. Singh SR (2013) Gastric cancer stem cells: a novel therapeutic target. Cancer Lett 338(1): 110-9.
29. Su YJ, Lai HM, Chang YW, Chen GY, Lee JL (2011) Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 30(15): 3186-3199.
30. Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, Honorio S, Xie Y, Scaglioni PP, DiMaio JM, Gazdar AF, Shay JW, Wistuba II, Minna JD (2010) Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 70(23): 9937-9948.
31. Sunaga H, Fujieda S, Tsuzuki H, Asamoto K, Fukuda M, Saito H (2001) Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions. Anticancer Res 21(4B): 2901-2906. (Pubitemid 33051149)
32. Tachibana M, Murai M (1998) G-CSF production in human bladder cancer and its ability to promote autocrine growth: a review. Cytokines Cell Mol Ther 4(2): 113-120. (Pubitemid 28356520)
33. Takaishi S,Okumura T, Tu S, Wang SS, ShibataW, Vigneshwaran R,Gordon SA, Shimada Y, Wang TC (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27(5): 1006-1020.
34. Torpy JM, Lynm C, Glass RM (2010) JAMA patient page. Stomach cancer. JAMA 303(17): 1771.
35. Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, Sentani K, Oue N, Yasui W (2012) Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int 62(2): 112-119.
36. Wang L, Xue J, Zadorozny EV, Robinson LJ (2008) G-CSF stimulates Jak2- dependent Gab2 phosphorylation leading to Erk1/2 activation and cell proliferation. Cell Signal 20(10): 1890-1899.
37. Wang T, Ong CW, Shi J, Srivastava S, Yan B, Cheng CL, Yong WP, Chan SL, Yeoh KG, Iacopetta B, Salto-Tellez M (2011) Sequential expression of putative stem cell markers in gastric carcinogenesis. Br J Cancer 105(5): 658-665.
38. Worthley DL, Giraud AS, Wang TC (2010) Stromal fibroblasts in digestive cancer. Cancer Microenviron 3(1): 117-125.
39. Yokoyama T, Hyodo M, Hosoya Y, Koinuma K, Kurashina K, Saitoh S, Hirashima Y, Arai W, Zuiki T, Yasuda Y, Nagai H, Kanai N, Saitoh K (2005) Aggressive G-CSF-producing gastric cancer complicated by lung and brain abscesses, mimicking metastases. Gastric Cancer 8(3): 198-201. (Pubitemid 41176100)